MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Annika Marx et al.|Cancer Cell|2017Cited by 607
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune MicroenvironmentGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Immunity|2018Cited by 216
Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancerGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Cancer Immunology Research|2020Cited by 0